Aclaris Therapeutics Inc. (NASDAQ:ACRS) Stock: Worth Taking a Bite?
Aclaris Therapeutics Inc. (NASDAQ:ACRS) previous close was $17.83 while the outstanding shares total 50.34M. The firm has a beta of 0.65. ACRS’s shares traded lower
Aclaris Therapeutics Inc. (NASDAQ:ACRS) previous close was $17.83 while the outstanding shares total 50.34M. The firm has a beta of 0.65. ACRS’s shares traded lower
Aclaris Therapeutics Inc. (NASDAQ:ACRS) shares traded lower over the last trading session, losing -5.30% on 06/09/21. The shares fell to a low of $16.82 before
Aclaris Therapeutics Inc. (NASDAQ:ACRS) Relative Strength Index (RSI) is 44.57, with weekly volatility at 6.62% and ATR at 1.35. The ACRS stock’s 52-week price range
Aclaris Therapeutics Inc. (NASDAQ:ACRS) shares fell to a low of $20.89 before closing at $21.03. Intraday shares traded counted 0.52 million, which was 10.9% higher
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne